Testing a new tool for men having a prostate biopsy
Part of Cancer, Kidney & urinary clinical trials.
This study evaluates a new test (PROSTia) that may help doctors better decide if a prostate biopsy is needed when prostate cancer is suspected. It aims to improve diagnosis by using a urine or blood sample before the biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man over 18 years old
- You are scheduled for a prostate biopsy because of high PSA, high PSA density, or an abnormal MRI
- You have never had a prostate biopsy before
- You are not under legal guardianship or in custody
- You understand French and can fill in a questionnaire (with help if needed)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is checking how well a blood test (liquid biopsy) can find prostate cancer and compare it to a special PET scan (PSMA-PET). If you qualify, you might help improve how we track prostate cancer without needing more invasive biopsies.
This trial tests a new blood test to help decide if you need a prostate biopsy. It may help men with high PSA levels or an abnormal rectal exam avoid unnecessary procedures.
This study looks for new urine markers (signals) that could help screen for prostate cancer. If you have a higher PSA blood test and are scheduled for a prostate biopsy, your urine sample may be studied to see if it can improve screening.
This study tests a new blood test (Proclarix) that may help doctors decide if a prostate biopsy is needed. It is for men with a slightly elevated PSA who are already considering a biopsy.
This study is testing a new approach to prostate biopsy that takes samples from around a suspicious area seen on MRI. It aims to see if this method can better detect prostate cancer compared to standard biopsy.
This study looks for urine markers (proteins and metabolites) that may help predict how prostate cancer patients respond to treatment and what their outcomes are. You may be asked to give a urine sample and allow use of your medical and treatment details for analysis (results are not shared with you).
Hear when a new Prostate Cancer (Adenocarcinoma) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.